Guardant Health (GH) Other Non-Current Liabilities (2018 - 2026)
Guardant Health's (GH) quarterly Other Non-Current Liabilities came in at $127.7 million in Q1 2026, up 37.98% year-on-year from $92.5 million in Q1 2025, and little changed quarter-over-quarter from $127.8 million in Q4 2025.
Guardant Health (GH) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Guardant Health has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $127.7 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $127.7 million, up 37.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $127.7 million (up 37.98% YoY), and the FY2025 annual result was $127.8 million, up 37.64% from the prior year.
- Other Non-Current Liabilities came in at $127.7 million for Q1 2026 at Guardant Health, roughly flat from $127.8 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $127.8 million in Q4 2025 to a low of $6.9 million in Q1 2022.
- The 5-year median for Other Non-Current Liabilities is $91.2 million (2025), against an average of $62.7 million.
- Across the five-year window, Other Non-Current Liabilities jumped 959.39% in 2024 and dropped 4.97% in 2025, its largest moves.
- Guardant Health's Other Non-Current Liabilities stood at $9.2 million in 2022, then soared by 945.93% to $96.0 million in 2023, then dropped by 3.3% to $92.8 million in 2024, then jumped by 37.64% to $127.8 million in 2025, then retreated by 0.06% to $127.7 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $127.7 million (Q1 2026), $127.8 million (Q4 2025), and $94.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Guardant Health | 17.09 Bn | 15.99 Bn | 196.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.69 Mn |
| Dec 31, 2025 | 127.77 Mn |
| Sep 30, 2025 | 94.36 Mn |
| Jun 30, 2025 | 91.17 Mn |
| Mar 31, 2025 | 92.55 Mn |
| Dec 31, 2024 | 92.83 Mn |
| Sep 30, 2024 | 89.45 Mn |
| Jun 30, 2024 | 95.93 Mn |
| Mar 31, 2024 | 96.79 Mn |
| Dec 31, 2023 | 96.01 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 9.14 Mn |
| Dec 31, 2022 | 9.18 Mn |
| Sep 30, 2022 | 6.99 Mn |
| Jun 30, 2022 | 9.29 Mn |
| Mar 31, 2022 | 6.91 Mn |
| Dec 31, 2021 | 3.93 Mn |
| Sep 30, 2021 | 3.42 Mn |
| Jun 30, 2021 | 2.49 Mn |